New Management

Starting from November 1st, SeSaM-Biotech will be under new managment.

Dominik Behrendt is taking over the lead of the company and will follow Dr. Alexander Schenk as CEO of SeSaM-Biotech.

"SeSaM is changing a lot these days" says fresh CEO Dominik Behrendt, "We have not only switched the management but will also move the operative business to Aachen, Germany. Despite all these changes we could ensure that the core knowledge is kept within the company - and we continue to deliver the finest SeSaM mutant libraries to our customers."

Dr. Schenk founded and lead SeSaM Biotech from the beginning in October 2008 winning multiple awards with his concept. The last month he guided the designated CEO Behrendt, enabling a smooth handover in the operations. We like to thank Dr. Schenk and wish him only the best for his future endeavours.